Takeda Pharmaceutical Stock Forward View
| TAK Stock | USD 17.43 0.06 0.34% |
Takeda Stock outlook is based on your current time horizon. Although Takeda Pharmaceutical's naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Takeda Pharmaceutical's systematic risk associated with finding meaningful patterns of Takeda Pharmaceutical fundamentals over time.
The relative strength index (RSI) of Takeda Pharmaceutical's share price is above 70 as of now. This usually implies that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Takeda, making its price go up or down. Momentum 73
Buy Stretched
Oversold | Overbought |
Quarterly Earnings Growth 3.302 | EPS Estimate Current Year 51.162 | EPS Estimate Next Year 109.66 | Wall Street Target Price 18.7076 | Quarterly Revenue Growth 0.042 |
Using Takeda Pharmaceutical hype-based prediction, you can estimate the value of Takeda Pharmaceutical Co from the perspective of Takeda Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Takeda Pharmaceutical using Takeda Pharmaceutical's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Takeda using crowd psychology based on the activity and movement of Takeda Pharmaceutical's stock price.
Takeda Pharmaceutical Short Interest
An investor who is long Takeda Pharmaceutical may also wish to track short interest. As short interest increases, investors should be becoming more worried about Takeda Pharmaceutical and may potentially protect profits, hedge Takeda Pharmaceutical with its derivative instruments, or be ready for some potential downside.
200 Day MA 14.8296 | Short Percent 0.0031 | Short Ratio 3.78 | Shares Short Prior Month 11.6 M | 50 Day MA 15.3756 |
Takeda Relative Strength Index
The Naive Prediction forecasted value of Takeda Pharmaceutical Co on the next trading day is expected to be 18.10 with a mean absolute deviation of 0.16 and the sum of the absolute errors of 9.62.Takeda Pharmaceutical Hype to Price Pattern
Investor biases related to Takeda Pharmaceutical's public news can be used to forecast risks associated with an investment in Takeda. The trend in average sentiment can be used to explain how an investor holding Takeda can time the market purely based on public headlines and social activities around Takeda Pharmaceutical Co. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Takeda Pharmaceutical's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Takeda Pharmaceutical.
Takeda Pharmaceutical Implied Volatility | 1.01 |
Takeda Pharmaceutical's implied volatility exposes the market's sentiment of Takeda Pharmaceutical Co stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Takeda Pharmaceutical's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Takeda Pharmaceutical stock will not fluctuate a lot when Takeda Pharmaceutical's options are near their expiration.
The Naive Prediction forecasted value of Takeda Pharmaceutical Co on the next trading day is expected to be 18.10 with a mean absolute deviation of 0.16 and the sum of the absolute errors of 9.62. Takeda Pharmaceutical after-hype prediction price | USD 17.51 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Takeda Pharmaceutical to cross-verify your projections. Prediction based on Rule 16 of the current Takeda contract
Based on the Rule 16, the options market is currently suggesting that Takeda Pharmaceutical Co will have an average daily up or down price movement of about 0.0631% per day over the life of the 2026-04-17 option contract. With Takeda Pharmaceutical trading at USD 17.43, that is roughly USD 0.011 . If you think that the market is fully incorporating Takeda Pharmaceutical's daily price movement you should consider acquiring Takeda Pharmaceutical Co options at the current volatility level of 1.01%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Takeda Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Takeda Pharmaceutical's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Takeda Pharmaceutical's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Takeda Pharmaceutical stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Takeda Pharmaceutical's open interest, investors have to compare it to Takeda Pharmaceutical's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Takeda Pharmaceutical is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Takeda. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Takeda Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Takeda price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Takeda using various technical indicators. When you analyze Takeda charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Takeda Pharmaceutical Cash Forecast
To forecast cash or other financial indicators, analysts must employ diverse statistical methods, techniques, and algorithms. This approach allows them to detect underlying patterns in the Takeda Pharmaceutical's financial statements, predicting their influence on future market prices.
Cash | First Reported 2008-12-31 | Previous Quarter 681.5 B | Current Value 655.4 B | Quarterly Volatility 203.4 B |
Takeda Pharmaceutical Naive Prediction Price Forecast For the 5th of February
Given 90 days horizon, the Naive Prediction forecasted value of Takeda Pharmaceutical Co on the next trading day is expected to be 18.10 with a mean absolute deviation of 0.16, mean absolute percentage error of 0.04, and the sum of the absolute errors of 9.62.Please note that although there have been many attempts to predict Takeda Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Takeda Pharmaceutical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Takeda Pharmaceutical Stock Forecast Pattern
| Backtest Takeda Pharmaceutical | Takeda Pharmaceutical Price Prediction | Research Analysis |
Takeda Pharmaceutical Forecasted Value
In the context of forecasting Takeda Pharmaceutical's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Takeda Pharmaceutical's downside and upside margins for the forecasting period are 16.97 and 19.22, respectively. We have considered Takeda Pharmaceutical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Takeda Pharmaceutical stock data series using in forecasting. Note that when a statistical model is used to represent Takeda Pharmaceutical stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.7855 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1577 |
| MAPE | Mean absolute percentage error | 0.0102 |
| SAE | Sum of the absolute errors | 9.6184 |
Predictive Modules for Takeda Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Takeda Pharmaceutical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Takeda Pharmaceutical After-Hype Price Density Analysis
As far as predicting the price of Takeda Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Takeda Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Takeda Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Takeda Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Takeda Pharmaceutical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Takeda Pharmaceutical's historical news coverage. Takeda Pharmaceutical's after-hype downside and upside margins for the prediction period are 16.38 and 18.64, respectively. We have considered Takeda Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Takeda Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Takeda Pharmaceutical is based on 3 months time horizon.
Takeda Pharmaceutical Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Takeda Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Takeda Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Takeda Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.41 | 1.13 | 0.08 | 0.35 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
17.43 | 17.51 | 0.46 |
|
Takeda Pharmaceutical Hype Timeline
On the 4th of February Takeda Pharmaceutical is traded for 17.43. The entity has historical hype elasticity of 0.08, and average elasticity to hype of competition of -0.35. Takeda is forecasted to increase in value after the next headline, with the price projected to jump to 17.51 or above. The average volatility of media hype impact on the company the price is over 100%. The price upswing on the next news is projected to be 0.46%, whereas the daily expected return is at this time at 0.41%. The volatility of related hype on Takeda Pharmaceutical is about 133.41%, with the expected price after the next announcement by competition of 17.08. The company reported the last year's revenue of 4.58 T. Total Income to common stockholders was 107.93 B with profit before taxes, overhead, and interest of 2.93 T. Considering the 90-day investment horizon the next forecasted press release will be in about 8 days. Check out Historical Fundamental Analysis of Takeda Pharmaceutical to cross-verify your projections.Takeda Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Takeda Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Takeda Pharmaceutical's future price movements. Getting to know how Takeda Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Takeda Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HLN | Haleon plc | 0.1 | 8 per month | 0.97 | 0.14 | 2.81 | (1.81) | 6.06 | |
| A | Agilent Technologies | (1.53) | 7 per month | 0.00 | (0.1) | 2.90 | (2.58) | 7.85 | |
| CAH | Cardinal Health | 2.07 | 9 per month | 0.48 | 0.18 | 2.69 | (1.71) | 18.07 | |
| INSM | Insmed Inc | (5.28) | 8 per month | 0.00 | (0.02) | 3.35 | (4.15) | 32.41 | |
| IQV | IQVIA Holdings | 0.08 | 12 per month | 0.00 | (0.07) | 2.57 | (2.04) | 6.41 | |
| ALC | Alcon AG | 0.47 | 10 per month | 1.04 | 0.02 | 3.24 | (1.98) | 6.78 | |
| RMD | ResMed Inc | 1.80 | 7 per month | 0.00 | (0.04) | 2.11 | (2.26) | 5.71 | |
| VEEV | Veeva Systems Class | (6.35) | 9 per month | 0.00 | (0.28) | 1.79 | (4.21) | 11.94 | |
| EW | Edwards Lifesciences Corp | 0.18 | 10 per month | 0.00 | (0.05) | 2.14 | (2.08) | 4.98 | |
| BDX | Becton Dickinson and | (0.01) | 7 per month | 0.79 | 0.11 | 2.93 | (1.77) | 7.14 |
Other Forecasting Options for Takeda Pharmaceutical
For every potential investor in Takeda, whether a beginner or expert, Takeda Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Takeda Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Takeda. Basic forecasting techniques help filter out the noise by identifying Takeda Pharmaceutical's price trends.Takeda Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Takeda Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Takeda Pharmaceutical could also be used in its relative valuation, which is a method of valuing Takeda Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Takeda Pharmaceutical Market Strength Events
Market strength indicators help investors to evaluate how Takeda Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Takeda Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Takeda Pharmaceutical stock market strength indicators, traders can identify Takeda Pharmaceutical Co entry and exit signals to maximize returns.
Takeda Pharmaceutical Risk Indicators
The analysis of Takeda Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Takeda Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting takeda stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.934 | |||
| Semi Deviation | 0.7887 | |||
| Standard Deviation | 1.26 | |||
| Variance | 1.6 | |||
| Downside Variance | 1.39 | |||
| Semi Variance | 0.6221 | |||
| Expected Short fall | (1.07) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Takeda Pharmaceutical
The number of cover stories for Takeda Pharmaceutical depends on current market conditions and Takeda Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Takeda Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Takeda Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Takeda Pharmaceutical Short Properties
Takeda Pharmaceutical's future price predictability will typically decrease when Takeda Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Takeda Pharmaceutical Co often depends not only on the future outlook of the potential Takeda Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Takeda Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.2 B | |
| Cash And Short Term Investments | 405.6 B |
Check out Historical Fundamental Analysis of Takeda Pharmaceutical to cross-verify your projections. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Takeda Pharmaceutical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 3.302 | Dividend Share 198 | Earnings Share 0.23 | Revenue Per Share | Quarterly Revenue Growth 0.042 |
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Takeda Pharmaceutical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.